PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Wednesday, January 12. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Pri-Med has more virtual education planned. View the schedule here.

Plan Your CME/CE Experiences



  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–11:30am ET    CME/CE Accredited Session


Strategies for Effective Pain Management in Clinical Practice

Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP


The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management in Clinical Practice curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including nonopioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

11:40am–12:25pm ET    Non-CME Industry Theater


The Changing Treatment Landscape for Uncontrolled Asthma

Neil Skolnik, MD


This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Neil Skolnik, MD

Neil Skolnik, MD

Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Sponsored by GlaxoSmithKline

12:35–1:35pm ET    CME/CE Accredited Session


Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation

Philip Schoenfeld, MD, MSEd, MSc


This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc.. 

1:45–2:45pm ET    CME/CE Accredited Session



This educational activity will review strategies to improve glycemic and extra-glycemic outcomes in patients with type 2 diabetes and explore the role of agents that target GIP and GLP-1 in the management of type 2 diabetes and obesity.

Silvio E. Inzucchi, MD

Professor of Medicine, Clinical Chief, Endocrinology, Medical Director, Yale Diabetes Center, Yale School of Medicine, Yale-New Haven Hospital

Anne Peters, MD

Professor of Clinical Medicine, USC Keck School of Medicine

Supported by Lilly. For further information concerning Lilly grant funding visit

2:55–3:40pm ET    Non-CME Industry Theater


Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Christopher Parker, DO


  1. Understand the causes and prevalence of chronic low back pain.
  2. Differentiate inflammatory back pain (IBP) from mechanical back pain.
  3. Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
  4. Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.

Christopher Parker, DO

Sponsored by AbbVie Inc.

3:50–4:50pm ET    CME/CE Accredited Session

Infectious Disease

COVID-19 Update: Panel Discussion (January 2022) 

Ty J. Gluckman, MD, FACC, FAHA | Charles Vega, MD, FAAFP


In this COVID-19 update, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community, Irvine, CA

5–5:45pm ET    Non-CME Industry Theater


Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?

Eden M. Miller, DO


Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.

Eden M. Miller, DO

Diabetes Care, Obesity, Family Medicine, Founder, Diabetes and Obesity Care, LLC, Bend, Oregon

Sponsored by Novo Nordisk